The Prevention of Cerebral Palsy in PreTerm Labour (PReCePT) programme was developed by the West of England AHSN in collaboration with University Hospitals Bristol and Weston NHS Foundation Trust and involved both patients and staff.
Selected as an AHSN Network national programme from April 2018 to March 2020, AHSNs worked with maternity hospitals in England to make MgSO4 available to mothers who go into labour at less than 30 weeks. It was the ﬁrst ever perinatal quality improvement (QI) programme delivered at scale across the whole country, bringing together midwives, obstetricians, and neonatologists.
This work mobilised the 15 AHSNs and the aligned drivers of the Maternal and Neonatal Health Safety Collaborative (MNHSC) and the national Patient Safety Collaboratives (PSCs) to support the aim of achieving 85% uptake of administration of MgSO4 to preterm babies in all maternity units in England.
At the end of the AHSN Network national programme all 152 maternity units in England had adopted PReCePT; the programme aim of 85% uptake had been achieved and variation in administration significantly reduced.
Adoption and spread or improvement methodology
The PReCePT programme took a network approach, delivering it through the 15 AHSNs.
The IHI model for improvement was used, which is based on three core questions and the Plan-Do-Study-Act cycle to test and accelerate improvement.
Co-designed with a range of stakeholders, a quality improvement (QI) toolkit and support materials were provided as well as practical tools and training.
These included toolkits, implementation guides and dashboards in addition to clinical role descriptions, training presentations and promotional collateral.
Midwife champions were funded to deliver PReCePT in each maternity unit and regional clinical leads were employed to support the delivery of the programme across each AHSN geographical area.